Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Clinical trial NCT01456715 · COMPLETED

Trial details

NCT number: NCT01456715
Sponsor: Laval University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus

Start date: 2008-09-01
Primary completion: 2018-12-01
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.